Lobaplatin-based chemotherapy with immunotherapy as first-line treatment in patients with advanced NSCLC: A real-world bidirectional cohort study.
Authors: Jiali Xu, Wenxin Zhou, Renhua Guo
Published: 2025-05-28
DOI:
10.1200/jco.2025.43.16_suppl.e20573
Source:
Full article
Abstract
e20573